Third, both the rates of, and factors associated with, treatment discontinuation were similar for GLP-1 receptor agonists and SGLT2 inhibitors, indicating that patient-specific factors, rather than drug-specific factors (such as side-effects), are driving treatment discontinuation
Lifestyle Factors: Lifestyle habits, including diet, exercise, and adherence to medication regimens, can also play a significant role in the efficacy of GLP-1 drugs
Ozempic and similar treatments can help some people lose up to 1020% of their body weight when combined with lifestyle changes
The same principles apply to tirzepatide and retatrutide, though specific guidelines for retatrutide will not exist until it reaches the market
Reduces Cravings and Late-Night Binges Powerful support for food control without stimulants